Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 13 min ago

InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer

Wed, 08/05/2015 - 13:22
New Leadership to Advance Cardiovascular Monitoring Company Into Commercialization Phase WEXFORD, PA--(Healthcare Sales & Marketing Network) - InteloMed, Inc., an emerging leader and developer of non-invasive cardiovascular monitoring technology, today ...
Devices, Cardiology, Monitoring, Personnel
InteloMed, CVInsight

Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer

Wed, 08/05/2015 - 13:15
SAN DIEGO and GAITHERSBURG, Md., Aug. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Mirati Therapeutics, Inc. ("Mirati") (MRTX), an oncology company focusing on genetic and epigenetic drivers of cancer, and MedImmune, the global biologics...
Biopharmaceuticals, Oncology
Mirati Therapeutics, MedImmune, AstraZeneca, mocetinostat

Hetero Announces the Launch of Biosimilar Rituximab (MABALL(TM)) in India

Wed, 08/05/2015 - 13:05
HYDERABAD, India, August 5, 2015 -- (Healthcare Sales & Marketing Network) --Hetero Group, one of India's leading generic pharmaceutical companies and one of the world's largest global producer of anti-retroviral drugs for HIV/AIDS treatment, today announ...
Biopharmaceuticals, Generics, Oncology, Product Launch
Hetero Group, biosimilar, Rituximab, MABALL, Rituxan, Genentech, Roche Group

Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer

Tue, 08/04/2015 - 17:50
MORAGA, Calif., Aug. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, announced today that the company h...
Biopharmaceuticals, Drug Delivery, Personnel
Trigemina , headache, migraine, intranasal oxytocin, oxytocin

Healeon Medical Names Dr. Robert Alexander as Chief Scientific Officer

Tue, 08/04/2015 - 16:17
Dr. Alexander Brings Years of Research and Clinical-Based Experience To The Healeon Team NEWBURY PARK, Calif., Aug. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Healeon Medical, Inc. is proud to announce the addition of Dr. Robert Alexander as ...
Regenerative Medicine, Personnel
Healeon Medical, CENTRIcyte 1000

Mevion Medical Systems Forming Joint Venture in China and Secures up to $200MM in Financing

Tue, 08/04/2015 - 16:13
Completion of financing with leading investors from China will support Mevion’s global commercialization strategy LITTLETON, Mass.--(Healthcare Sales & Marketing Network)--Mevion Medical Systems, the leading provider of advanced proton therapy systems, ...
Devices, Oncology, Venture Capital
Mevion Medical Systems, proton therapy, radiotherapy

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms

Tue, 08/04/2015 - 16:08
PHOENIX, AZ--(Healthcare Sales & Marketing Network) - Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its pharmac...
Biopharmaceuticals, Neurology, FDA
Insys Therapeutics, cannabidiol, Infantile Spasm

Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio

Tue, 08/04/2015 - 16:04
MARLBOROUGH, Mass., Aug. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) has closed on the previously announced agreement with Endo International plc (ENDP) (ENL.TO) to purchase American Medical Systems' (AMS) Men'...
Devices, Urology, Acquisitions
Boston Scientific, American Medical Systems

Gynesonics Announces New CPT Code Established for Sonata(TM) System

Tue, 08/04/2015 - 15:59
AMA Establishes Code for Reimbursement of the Innovative Procedure for Uterine Fibroids REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for...
Devices, Reimbursement
Gynesonics, Sonata System, Uterine Fibroid Ablation, Uterine Fibroid

Galleon Pharmaceuticals Names Joseph Oliveto as Chief Executive Officer

Tue, 08/04/2015 - 15:57
Former CEO of Chelsea Therapeutics to Lead Galleon’s Development and Commercialization of Pharmaceuticals for Sleep Apnea and Related Disorders HORSHAM, Pa.--(Healthcare Sales & Marketing Network)--Galleon Pharmaceuticals, the first company to build a d...
Biopharmaceuticals, Personnel
Galleon Pharmaceuticals, sleep apnea

TriVascular Technologies, Inc. Receives FDA Approval of the Ovation iX(TM) Abdominal Stent Graft System

Tue, 08/04/2015 - 15:54
Next Generation Aortic Body Delivery System Approval Continues Strong Cadence of New Product Introductions SANTA ROSA, Calif., Aug. 4, 2015 -- (Healthcare Sales & Marketing Network) -- TriVascular Technologies, Inc. (TRIV) announced today that the U.S. ...
Devices, Interventional, FDA
TriVascular Technologies, Ovation iX, Stent Graft, abdominal aortic aneurysm

FDA Approves the First 3D Printed Drug Product

Mon, 08/03/2015 - 20:17
Aprecia Introduces its First Product Using the ZipDose® Formulation Platform for the Treatment of Epilepsy BLUE ASH, Ohio, Aug. 3, 2015 -- (Healthcare Sales & Marketing Network) -- Aprecia Pharmaceuticals Company today announced that the U.S. Food ...
Biopharmaceuticals, Drug Delivery, Neurology, FDA
Aprecia Pharmaceuticals, SPRITAM, levetiracetam, epilepsy

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

Mon, 08/03/2015 - 18:36
Synthon’s glatiramer acetate, a potential generic version of Copaxone®1 for the treatment of relapsing remitting multiple sclerosis is currently being reviewed by the U.S. Food and Drug Administration NEW YORK & NIJMEGEN, Netherlands--(Healthcare S...
Biopharmaceuticals, Neurology
Pfizer, Synthon, glatiramer, Copaxone, Multiple Sclerosis

CytomX Announces Management Team Promotions

Mon, 08/03/2015 - 18:32
SOUTH SAN FRANCISCO, Calif., Aug. 3, 2015 -- (Healthcare Sales & Marketing Network) -- CytomX, a biopharmaceutical company developing Probody™ therapeutics for the treatment of cancer, today announced the promotion of several members of its leadership tea...
Biopharmaceuticals, Oncology, Personnel
CytomX Therapeutics, Probody

Presbia PLC Appoints Dr. Gerd Auffarth to the Board of Directors

Mon, 08/03/2015 - 18:30
Dr. Mark Blumenkranz Transitions to the Presbia Medical Advisory Board DUBLIN--(Healthcare Sales & Marketing Network)--The Board of Directors of Presbia PLC (LENS), an ophthalmic device company and leader in near vision restoration, announced today that...
Devices, Ophthalmology, Personnel
Presbia, Flexivue Microlens, presbyopia

Gore Applauds Medicare Announcement to Reclassify Endovascular Abdominal Aneurysm Repairs

Mon, 08/03/2015 - 18:25
Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms FLAGSTAFF, Ariz.--(Healthcare Sales & Marketing Network)--W. L. Gore & Associates, Inc. (Gore) applauds the recent reclassific...
Devices, Interventional, Reimbursement
W. L. Gore, Endoprosthesis, abdominal aortic aneurysm

Intra-Cellular Therapies Expands Leadership Team

Mon, 08/03/2015 - 18:20
NEW YORK, Aug. 3, 2015 -- (Healthcare Sales & Marketing Network) -- Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announces the expansion of its sen...
Biopharmaceuticals, Neurology, Personnel
Intra-Cellular Therapies, Parkinson's, Alzheimer's

Soligenix Enters into a $10 Million Equity Purchase Agreement

Mon, 08/03/2015 - 18:17
PRINCETON, N.J., Aug. 3, 2015 -- (Healthcare Sales & Marketing Network) -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncolog...
Biopharmaceuticals, Oncology, Venture Capital
Soligenix, photodynamic therapy, T-cell lymphoma

Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries

Mon, 08/03/2015 - 18:14
Approval by the European Commission Follows Unanimous Recommendation by the EMA SEATTLE, Aug. 3, 2015 -- (Healthcare Sales & Marketing Network) -- Omeros Corporation (OMER) today announced that the European Commission (EC) has granted marketing authori...
Biopharmaceuticals, Ophthalmology, Regulatory
Omeros Corp, Omidria, phenylephrine, ketorolac

CMS Approves Add-on Payment for Lutonix(R) Drug-Coated Balloon for Inpatient Use

Mon, 08/03/2015 - 18:11
MURRAY HILL, N.J.--(Healthcare Sales & Marketing Network)--C. R. Bard, Inc. (BCR) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a new technology add-on payment for the Lutonix® Drug-Coated Balloon (DCB) und...
Devices, Interventional, Reimbursement
C. R. Bard, Lutonix, Drug-Coated Balloon, peripheral arterial disease

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong